Biosimilars

Latest News

HCPLive Biosimilar Month in Review
Biosimilars Month in Review: November 2024

December 6th 2024

The biosimilars month in review highlights new equivalency data for denosumab and tocilizumab biosimilars.

Gerd R. Burmester, MD, Professor of Medicine, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, and Humboldt University and Free University
Tocilizumab Biosimilar Demonstrates Similar Safety, Efficacy for RA to Reference

December 6th 2024

Jean-Yves Reginster, MD, PhD, Outstanding Professor of Epidemiology, Public Health and Health Economics, and Professor of Bioethics and Societal Medicine, and Honorary Chair of the Bone and Cartilage Metabolism Unit, at the University of Liège
Denosumab Biosimilar Demonstrates Equivalent Efficacy, Safety in Phase 3 Trial

December 3rd 2024

FDA Accepts BLA for Denosumab Biosimilar
FDA Accepts BLA for Denosumab Biosimilar

November 6th 2024

HCPLive Biosimilar Month in Review
Biosimilars Month in Review: October 2024

November 2nd 2024

© 2024 MJH Life Sciences

All rights reserved.